Here we work on new cancer treatments every day. Promising drugs are given a place in our healthcare for the first time in phase 1 and 2 studies. Together we carefully look at safety, effect and dosage. This is how we take the first, important step from laboratory to patient.
For the playback of videos, we need permission to place cookies. You can indicate this via the cookie banner. If you do not want this, you can watch the video directly on the platform via the link below.
Watch the video on Youtube here
This translation was generated automatically based on information in Dutch. It has not been reviewed by a medical specialist. The purpose of this translation is to make our information accessible to non-Dutch speakers. However, this information should not be considered a substitute for medical advice from your treating physician. The Netherlands Cancer Institute cannot guarantee the accuracy of this translation. For medical questions or advice, please consult your physician.
The NKI Centre for Early Clinical Studies places functional cookies and analytical cookies with very little or no privacy impact, unless you give permission for other cookies (as shown below). More information can be found in our cookie statement at the bottom of this page.
Cookie Information
Accept cookies!
nl
